Torrent Pharmaceuticals Ltd.
Snapshot View

1537.40 +43.10 ▲2.9%

29 September 2022, 01:25:59 PM
Volume: 389,002

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.torrentpharma.com
Market Cap 52,294.90 Cr.
Enterprise Value(EV) 54,151.36 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 23.67 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 65.29 Trailing Twelve Months Ending 2022-06
Industry PE 30.82 Trailing Twelve Months Ending 2022-06
Book Value / Share 188.85 Trailing Twelve Months Ending 2022-06
Price to Book Value 8.18 Calculated using Price: 1,545.15
Dividend Yield 1.55 Period Ending 2022-03
No. of Shares Subscribed 33.84 Cr. 338,445,440 Shares
FaceValue 5
Company Profile
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+2.88%
1 Week
-0.02%
1 Month
-0.26%
3 Month
+8.27%
6 Month
+9.43%
1 Year
-1.92%
2 Year
+13.41%
5 Year
+149.79%
10 Year
+785.50%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 39.94 34.19 57.92 23.80 15.12 9.34 21.47 23.49 13.18
Return on Capital Employed (%) 35.06 26.98 45.63 20.36 13.81 9.75 15.28 17.62 14.35
Return on Assets (%) 15.16 11.71 20.89 10.28 5.81 3.15 7.50 9.20 5.92

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 1,422 1,902 2,491 3,494 4,350 4,622 4,724 4,823 5,837 5,953
Non Curr. Liab. 620 927 2,505 1,995 2,303 4,142 3,861 3,299 2,924 2,238
Curr. Liab. 1,711 2,175 2,824 3,285 2,738 5,202 5,165 5,454 4,892 4,415
Minority Int. 0 0 0 0 0 1
Equity & Liab. 3,753 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606
Non Curr. Assets 1,192 1,600 3,768 4,086 4,513 8,705 8,714 8,596 8,130 7,312
Curr. Assets 2,561 3,404 4,051 4,689 4,879 5,262 5,038 4,981 5,523 5,295
Misc. Exp. not W/O
Total Assets 3,753 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 4,185 4,653 6,667 5,816 5,950 7,673 7,939 8,005 8,508 8,723
Other Income 38 286 229 223 307 64 121 57 197 185
Total Income 4,223 4,939 6,896 6,039 6,257 7,736 8,061 8,061 8,705 8,908
Total Expenditure -3,233 -3,633 -3,937 -4,438 -4,609 -5,696 -5,769 -5,524 -6,077 -6,252
PBIDT 990 1,306 2,959 1,601 1,648 2,040 2,292 2,537 2,628 2,656
Interest -59 -175 -184 -206 -308 -504 -451 -353 -255 -245
Depreciation -87 -191 -238 -307 -409 -618 -654 -658 -662 -652
Taxation -180 -189 -610 -155 -253 -125 -162 -274 -449 -473
Exceptional Items -194 -357 -485 -485
PAT 664 751 1,733 934 678 436 1,025 1,252 777 801
Minority Interest 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 664 751 1,733 934 678 436 1,025 1,252 777 801
Adjusted EPS 20 22 51 28 20 13 30 37 23 24

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 153 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803
Cash Fr. Inv. -242 -356 -2,162 -838 -787 -4,707 -241 199 -449 -197
Cash Fr. Finan. 20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781
Net Change -68 330 -140 469 29 -395 242 42 -95 -175
Cash & Cash Eqvt 687 955 865 1,050 1,068 702 940 662 573 398

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
Public 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 28 Sep 2022
Acquisition
Torrent Pharmaceuticals Limited has informed the Exchange about execution of definitive agreements in relation to acquisition of 100% stake in Curatio Health Care (I) Private Limited
Wed, 28 Sep 2022
Closure of trading window
Torrent Pharmaceuticals Limited has informed the Exchange about Closure of trading window
Wed, 28 Sep 2022
Investor Presentation
Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation

Technical Scans View Details >>

Wed, 28 Sep 2022
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week High Zone Close Within 52 Week High Zone

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 220,222.96 929.45 +1.3%
Divi's Laboratories Ltd. 98,114.53 3,707.50 +0.1%
Cipla Ltd. 88,495.80 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. 71,034.40 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. 61,344.29 4,376.70 +2.5%
Alkem Laboratories Ltd. 39,477.37 3,192.30 -3.2%
Max Healthcare Institute Ltd. 39,199.20 398.00 -2.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 56.55 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.60 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-06 35.56 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.75 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.44 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-06 30.25 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 62.13 398.00 -2.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.39 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.89 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-06 4.12 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.51 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.32 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-06 4.50 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.09 398.00 -2.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 0.30 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 398.00 -2.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 398.00 -2.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 20.99 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 398.00 -2.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 10,634.19 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 398.00 -2.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 929.45 +1.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,707.50 +0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.10 +0.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,370.05 +2.4%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,376.70 +2.5%
Alkem Laboratories Ltd. Consolidated 2022-03 1,680.32 3,192.30 -3.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 398.00 -2.0%

FAQ's On Torrent Pharmaceuticals Ltd.

What is Torrent Pharma share price?

Can I buy Torrent Pharma shares now?

What is the Dividend Yield of Torrent Pharma?

What is the Market Cap of Torrent Pharma?

What are the key metrics to analyse Torrent Pharma?

What is the 52 Week High and Low of Torrent Pharma?

What is the trend of Torrent Pharma share price?